The biological importance of this growth factor, in head and neck cancer progression, is supported by the findings demonstrating that survival of HNSCC patients correlates significantly with TGFα protein expression levels in the primary tumour, independent of other clinical and pathological parameters including the presence of regional metastases (N-stage) [75,78]. Here, TGFA is linked to head and neck cancer.